Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can i get advil cashback with your app?How is lipitor's composition designed to impact insulin resistance?What's the minimum lipitor dosage before benefits decrease?Does lipitor work better on an empty stomach?How does alcohol impact cosentyx's potency?
See the DrugPatentWatch profile for vascepa
Why Are Vascepa Rebatable at Pharmacies? Vascepa, a prescription medication containing icosapent ethyl, is used to lower triglyceride levels in adults with severe hypertriglyceridemia. In 2019, Vascepa was approved by the FDA for a second indication to reduce the risk of cardiovascular events in adults with elevated triglyceride levels. The medication's rebates may stem from these expanded indications, its high price point, or efforts by pharmacies to increase patient access and adherence [1]. Pharmacies Offering Vascepa Rebatable Prices Some pharmacies offer Vascepa rebates or discounts to help make the medication more affordable for patients. These may include: - GoodRx: GoodRx, a popular prescription savings platform, offers discounts on Vascepa. Patients can pay as little as $25 for a 30-day supply, depending on their insurance and location [2]. - RxSaver: RxSaver is another platform offering Vascepa discounts. Patients can fill their prescription at a local pharmacy and potentially save up to 80% on their medication [3]. - Pharmacy Discounts: Some pharmacies, such as Walgreens or CVS Pharmacy, may also offer Vascepa discounts or rebates through their loyalty programs or other promotions [4]. - Manufacturer-Backed Programs: Amarin, the manufacturer of Vascepa, offers a Patient Assistance Program (PAP) to eligible patients who cannot afford their medication. Patients can contact Amarin directly to inquire about eligibility and program details [5]. Patent and Exclusivity Considerations As of my knowledge cutoff in 2023, Vascepa's exclusivity was set to expire in 2028. However, a court ruling in 2022 extended the exclusivity period for Vascepa until 2030 [6]. This extension may impact the availability of generic alternatives and the rebatable price landscape for the medication. Sources: [1] DrugPatentWatch.com https://www.drugpatentwatch.com/patents/20200004082 [2] GoodRx https://www.goodrx.com/vascepa [3] RxSaver https://www.rxsaver.co/vascepa [4] Pharmacy Discounts https://www.cvspharmacy.com/health-information/pharmacy-discounts https://www.walgreens.com/pharmacy-discounts [5] Amarin Patient Assistance Program https://www.amarincr.com/patient-assistance-program [6] Amarin Corporation plc https://www.amarincr.com/news-and-investors/press-releases/
Other Questions About Vascepa :